Related Experiment Video

Updated: Jun 10, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

[Research Advance of TRAIL Molecular Target in the Therapy of Lung Cancer.]

Qian Liu1, Lingdi Ma, Yong Wang

  • 1Laboratory center, Second Changzhou Hospital Affiliated to Nanjing Medical University, Changzhou 213003, China.

Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|August 19, 2010
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Experiment Videos

Last Updated: Jun 10, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Downregulation of lncRNA SNHG14 Alleviates Neuropathic Pain and Inflammation in CCI Rats by Targeting miR-182-5p/BDNF.

Neurochemical research·2026

Matrine induces V-ATPase-dependent cytoplasmic vacuolation and inhibits the function of the lysosome in leukemia cells.

Pharmaceutical science advances·2026

Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating glycolysis and the TCA cycle.

Nature communications·2024

De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence.

Nature cell biology·2023

Identification of purine biosynthesis as an NADH-sensing pathway to mediate energy stress.

Nature communications·2022

Matrine, a potential c-Myc inhibitor, suppresses ribosome biogenesis and nucleotide metabolism in myeloid leukemia.

Frontiers in pharmacology·2022

[Tumor Cell and Brain Microenvironment Interactions in Non-small Cell Lung Cancer Brain Metastasis: Mechanisms and Emerging Insights].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2026

[Advances in Radiomics for Immune Checkpoint Inhibitor-related Pneumonitis of Lung Cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2026

[Etiology, Evaluation and Comprehensive Management of Hoarseness after Lung Cancer Surgery].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2026

[Research Progress on Circulating Tumor DNA Status and Postoperative Central Nervous System Recurrence Risk and Overall Survival in Non-small Cell Lung Cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2026

[Digital Drainage Systems in Postoperative Chest Tube Management after Pulmonary Resection: Current Status and Future Perspectives].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2026

[Clinical Frontiers and Applications Progress of ctDNA in Precision Treatment of Non-small Cell Lung Cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2026

Gedatolisib after CDK4/6 inhibition in HR-Positive/HER2-negative advanced breast cancer: pharmacology, phase iii evidence, and therapeutic positioning.

Expert opinion on pharmacotherapy·2026

Integrated network toxicology, transcriptomic, and Mendelian randomization analyses explore potential molecular links between acrylamide exposure and clear cell renal cell carcinoma.

Medicine·2026

Completed clinical trials of p53-targeted therapeutic strategies in cancer: A cross-sectional ClinicalTrials.gov registry analysis.

Medicine·2026

PLCG1 regulates pyroptosis to inhibit the progression of non-small cell lung cancer: A Mendelian randomization study.

Medicine·2026

Screening of Modular Self-Assembling Peptides for Targeting the MDM2 Protein.

Journal of peptide science : an official publication of the European Peptide Society·2026

GPR68 Inhibition Induces Ferroptosis in Atypical Teratoid Rhabdoid Tumors.

Cancer reports (Hoboken, N.J.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us